Status:
UNKNOWN
Protective Effect of Phenytoin on Glaucoma
Lead Sponsor:
Rabin Medical Center
Conditions:
Primary Open Angle Glaucoma
Secondary Open Angle Glaucoma
Eligibility:
All Genders
18+ years
Brief Summary
since glaucoma is considered an optic neuropathy, new treatments for glaucoma are being continuously investigated, including neuroprotection. Previous studies implied that phenytoin, a potent anti-co...
Detailed Description
The study will examine adult patients who suffer from glaucoma and epileptic disorders on the same time. the study group will include glaucoma patients, being treated with oral Phenytoin for their epi...
Eligibility Criteria
Inclusion
- Clinical diagnosis of glaucoma
- chronic treatment with phenytoin for any indication
Exclusion
- pregnancy
- visual acuity less then 6/60
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00739154
Start Date
November 1 2008
End Date
December 1 2010
Last Update
August 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beilinson hospital, Rabin medical center
Petah Tikva, Israel, 49100